← Back to Search

Team Clinic Care for Type 1 Diabetes

N/A
Waitlist Available
Led By Jennifer K Raymond, MD, MCR
Research Sponsored by Children's Hospital Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of type 1 diabetes > 6 month duration
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline (0), 3 months, 6 months, 9 months, 12 months
Awards & highlights

Study Summary

This trial is to study if the team clinic care model is more effective than standard care for patients with T1D.

Who is the study for?
This trial is for English-speaking middle and high school students with Type 1 Diabetes, who have been diagnosed for over 6 months. They shouldn't be in other group interventions or have serious medical conditions like cystic fibrosis, uncontrolled thyroid disease, or severe behavioral/psychological issues that could affect group participation.Check my eligibility
What is being tested?
The study tests a new 'Team Clinic' care approach against standard care for managing Type 1 Diabetes. It involves virtual appointments and possibly in-person visits with a multidisciplinary team. Participants are randomly placed into one of four groups to compare the effects of these different approaches over 15 months.See study design
What are the potential side effects?
Since this trial focuses on diabetes management through virtual care rather than medication, traditional side effects aren't expected. However, participants may experience varying levels of satisfaction or effectiveness with the virtual healthcare model.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with type 1 diabetes for over 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline (0), 3 months, 6 months, 9 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline (0), 3 months, 6 months, 9 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hemoglobin A1C Progression
Hemoglobin A1C at Baseline
Number of Standard Care cohort participants completing appointments
+8 more
Secondary outcome measures
Clinical Efficiency
Cost to Instituition
Cost to Institution
+19 more
Other outcome measures
ADA and CCS standards
Clinical Variables
Diabetes Family Responsbility Questionnaire - Parent
+16 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: Team Clinic: Virtual Team Clinic GroupExperimental Treatment1 Intervention
Participants will be invited to participate in online/virtual thematic group sessions led by Team Clinic group facilitators (e.g., RD, SW, RN) aimed at improving glycemic control and treatment adherence, increasing social supports and diabetes care satisfaction, and aid in the transition from caregiver led treatment to self care. o Patients and Family members attend their own online sessions: Energy Training, Proficiency Training, Resilience Training, Balance Training, Miscellaneous sessions - scheduled as needed
Group II: Team Clinic Care: No VTC GroupsExperimental Treatment1 Intervention
Participants attend quarterly visits (1 visit every 3months). Appointments scheduled for Telehealth (TH) (1 in-person visits) as decided by provider/patient and yearly team visit as needed • Providers will utilize a patient centered care approach to conducting appointments
Group III: Standard Care: Virtual Team ClinicExperimental Treatment1 Intervention
Appointments will continue as usually with provider (quarterly visits; 1 visit every 3 months), but will be referred for necessary care per usual methods (e.g., diabetes education or supportive services). o Patients and Family members attend their own online sessions: Energy Training, Proficiency Training, Resilience Training, Balance Training, Miscellaneous sessions - scheduled as needed
Group IV: Standard Care: No VTC GroupsExperimental Treatment1 Intervention
Appointments will continue as usually with provider (quarterly visits; 1 visit every 3 months), but will be referred for necessary care per usual methods (e.g., diabetes education or supportive services).

Find a Location

Who is running the clinical trial?

Children's Hospital Los AngelesLead Sponsor
232 Previous Clinical Trials
5,076,393 Total Patients Enrolled
University of Southern CaliforniaOTHER
906 Previous Clinical Trials
1,596,209 Total Patients Enrolled
Cedars-Sinai Medical CenterOTHER
500 Previous Clinical Trials
164,820 Total Patients Enrolled

Media Library

Standard Care Clinical Trial Eligibility Overview. Trial Name: NCT04190368 — N/A
Type 1 Diabetes Research Study Groups: Team Clinic: Virtual Team Clinic Group, Team Clinic Care: No VTC Groups, Standard Care: Virtual Team Clinic, Standard Care: No VTC Groups
Type 1 Diabetes Clinical Trial 2023: Standard Care Highlights & Side Effects. Trial Name: NCT04190368 — N/A
Standard Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04190368 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scale of involvement in this experiment?

"Affirmative. Data hosted on clinicaltrials.gov displays that this examination, which was first published on September 7th 2021, is actively enrolling individuals. Approximately 200 patients need to be recruited from one medical centre."

Answered by AI

What is the expected outcome of this trial?

"The primary objective of this medical trial, which will be evaluated over the course of 12 months, is to examine the number of standard care cohort participants that complete appointments. Additional objectives include evaluating cost to institution for those receiving in-person treatment; a polar yes or no questionnaire inquiring about appointment attendance and duration; self-reported episodes of diabetic ketoacidosis in past three months as well as Electronic Medical Records (EMR); and Problem Areas in Diabetes instrument designed to assess emotional distress related caregivers with teens suffering from diabetes using a 6 point Likert Scale format."

Answered by AI

What criteria must an individual possess to be eligible for participation in this experiment?

"This study aims to recruit 200 minors (aged 10-17) with type 1 diabetes mellitus. The essential eligibility criteria for applicants are the following: Behavioural or developmental disabilities in parent/child, Mental health conditions which make group participation challenging, Grade level from 6th to 12th at time of intervention, No prior involvement in other group interventions and exclusion due to severe comorbid medical issues (like cystic fibrosis)."

Answered by AI

Does the medical trial accept elderly individuals as participants?

"This clinical trial requires that participants range in age from 10 to 17. In addition, there are 218 studies for minors and 925 for adults of senior years."

Answered by AI

Does this medical study currently accept participants?

"Correct. According to the information publicly available on clinicaltrials.gov, this medical research is actively recruiting participants since its initial posting date of September 7th 2021, and has a goal of 200 patients from one location."

Answered by AI
Recent research and studies
~2 spots leftby May 2024